| |
Site Navigation
|
 |
|
ALL
WOMEN SHOULD KNOW THEIR RISK FOR BREAST CANCER...
Now They Can With A Simple First-Morning Urine Test
Researchers
at Rockefeller University have found that the body metabolizes estrogens
into several different metabolites that can impact cancer development.
One metabolite, 2-hydroxyestrone (2-OHE1), tends to inhibit cancer growth.
Another, 16-alpha-hydroxyestrone (16-a-OHE1), actually encourages tumor
development, and is often found elevated in women with breast cancer.
Measuring the ratio of these two metabolites provides an important indication
of risk for future development of estrogen-sensitive cancers.
Estronex 2/16 ratios less than 2.0 indicate increased risk for breast cancer.
High levels of 21-OHE1 raise Estronex 2/16 ratios, reducing the risk for
breast, cervical and other estrogen-sensitive cancers.
The optimal Estronex 2/16 ratio is 2.0-8.0.
Supplements containing DIM (diindolyl-methane) or I-3-C (Indole-3-carbinol)
have been shown to rise Estronex 2/16 ratios. Cruciferous vegetables, such
as broccoli, cauliflower are significant sources of I-3-C.
Ground flaxseed and soy isoflavones also favorably benefit the Estronex
2/16 ratio.
-->
return to menu / back ... (click)
--> return to top of the page (click)
|
|
